Corvita 150
- Form
- Tablet
- Product type
- Multivitamin & Mineral (MVM)
- Servings
- 150 servings
- Serving size
- 1 tablets
Ingredients
Supplement Facts
- Serving size
- 1 tablets
- Servings
- 150 servings
| Ingredients | Amount | %DV |
|---|---|---|
| Vitamin CVitamin C | 120 mg | 133% |
| Vitamin B6Pyridoxine Hydrochloride | 10 mg | 588% |
| Folate (Folic Acid) | 2,083 mcg DFE | 521% |
| Folate (Folic Acid) | 1,250 mcg | — |
| Vitamin B12Cyanocobalamin | 15 mcg | 625% |
| IronFerronyl Carbonyl Iron | 150 mg | 833% |
| ZincZinc Citrate | 25 mg | 227% |
Show other ingredientsHide other ingredients10
Ingredients listed outside the Supplement Facts panel. Amounts and %DV are not required there, so they are not recorded.
| Ingredients | Form |
|---|---|
| Microcrystalline Cellulose | — |
| pregelatinized Starch | — |
| Polyvinyl Alcohol | — |
| Polyethylene Glycol | — |
| FD&C Red #40 Lake | — |
| Talc | — |
| Titanium Dioxide | — |
| Croscarmellose Sodium | — |
| Magnesium Stearate | — |
| Stearic Acid | — |
Source: DSLD (US NIH) label ID 264418Amounts are as stated on the product label. Check the latest label before you buy.
Where to buy
Intended for
- Adults
- Sugar Free
- Gluten free
Label directions and warnings
Quoted from the label as written. Marketing statements, such as claimed benefits, are not shown.
- Directions
- Directions for use Take one tablet by mouth daily or as directed by a physician.
- Precautions
- Contraindications: Corvita 150 should not be used by patients with a known hypersensitivity to any of the listed ingredients. All iron compounds are contraindicated in patients with hemochromatosis, hemosiderosis, or hemolytic anemias.
- Precautions General: Do not exceed recommended dose. The type of anemia and the underlying cause or causes should be determined before starting therapy with Corvita 150. Since the anemia may be a result of a systemic disturbance, such as recurrent blood loss, the underlying cause or causes should be corrected, if possible.
- Geriatric Use: Safety and effectiveness in elderly populations have not been established.
- Adverse Reactions Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stools and abdominal pain. Adverse reactions with iron therapy are usually transient.
- Overdosage The clinical course of acute iron overdosage can be variable. Initial symptoms may include abdominal pain, nausea, vomiting, diarrhea, tarry stools, melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemia, dehydration, drowsiness, pallor, cyanosis, lassitude, seizures, shock and coma.
- Call your doctor about side effects. To report side effects, call Trigen Laboratories at 1-888-9-TRIGEN (1-877-987-4436) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
- Precautions: children
- Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
- Pediatric Use: Safety and effectiveness in pediatric populations have not been established.
- Precautions: pregnancy, nursing, medications
- The patient’s medical conditions and consumption of other drugs, herbs, and/or supplements should be considered.
- Drug Interactions There is a possibility of increased bleeding due to pyridoxine interaction with anticoagulants (e.g., Aspirin, Heparin, Clopidogrel).
- Precautions: allergies
- Folic Acid: Folic acid alone is an improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurologic manifestations remain progressive. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
- Does not contain
- Gluten-, Lactose- and Sugar-free
- Storage
- Storage Store at 20 degrees -25 degrees C (68 degrees -77 degrees F), excursions permitted to 15 degrees-30 degrees C (59 degrees-86 degrees F) [See USP Controlled Room Temperature]. Protect from light and moisture and avoid excessive heat. Dispense in a tight, light resistant container as defined in the USP using a child-resistant closure.